FUNDAMENTALS
EdgeFII/DII
LALPATHLABDR. LAL Path Labs
₹1,989.00+1.31%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
LALPATHLABNSE · EquityHealthcare Services

DR. LAL Path Labs

ISIN
INE600L01024
Instrument key
NSE_EQ|INE600L01024
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹1,989.00+25.80 · +1.31%
Day rangecircuit ₹1,604.80 – ₹2,407.20
1,940.00
2,028.20

as of 21/11/2026, 11:42:02 am

Open
₹1,950.00
Day high
₹2,028.20
Day low
₹1,940.00
Prev. close
₹1,963.20
Volume
2.65 L
VWAP
₹2,012.21

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

6 months · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M
1Y
5Y
MAX
Change · 6M
+19.35%
1,680.80 → 2,006.00
Period high
₹2,079.00
9/11/2026
Period low
₹1,500.10
8/6/2026
From high
-3.51%
+33.72% from low
Avg volume
3.84 L
4.87 Cr total
Volatility · ann.
24.0%
127 candles · 60 up / 67 down
20 Nov 2026O 1,950.00H 2,028.20L 1,940.00C 2,006.00Vol 2.65 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data127 rows of open, high, low, close and volumeShowHide
20 Nov 20261,950.002,028.201,940.002,006.00+2.87%88.202.65 L
19 Nov 20261,957.001,978.901,948.401,963.20+0.32%30.501.96 L
18 Nov 20261,972.301,998.301,950.001,965.40-0.35%48.301.86 L
17 Nov 20261,997.002,015.501,971.201,980.20-0.84%44.301.08 L
16 Nov 20261,982.002,025.301,966.202,000.70+0.94%59.102.14 L
13 Nov 20262,008.802,025.001,977.001,993.00-0.79%48.001.45 L
12 Nov 20262,028.702,049.001,998.102,008.80-0.98%50.902.34 L
11 Nov 20262,040.002,065.002,016.002,028.70-0.55%49.005.40 L
9 Nov 20262,008.802,079.001,990.102,016.50+0.38%88.903.40 L
8 Nov 20262,010.002,017.601,997.002,008.80-0.06%20.6035.2K

Historical price and volume data · Showing 1–10 of 127

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

57.28
Company
57.28
Sector
55.28

Worse than sector by 4%

P/B

Price ÷ book value per share

12.27
Company
12.27
Sector
3.05

Worse than sector by 302%

ROA

Net income ÷ total assets

17.01%
Company
17.01%
Sector
4.2%

Better than sector by 305%

ROE

Net income ÷ shareholders' equity

21.32%
Company
21.32%
Sector
-31.98%

Better than sector by 167%

ROCE

EBIT ÷ capital employed

26.75%
Company
26.75%
Sector
11.89%

Better than sector by 125%

Quick Ratio

Liquid assets ÷ current liabilities

3.38
Company
3.38
Sector
32.98

Worse than sector by 90%

EV/EBITDA

Enterprise value ÷ EBITDA

32.82
Company
32.82
Sector
23.22

Worse than sector by 41%

04/Business

About the company

Sector: Healthcare Services

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

Sector market cap (INR)
₹33,680 Cr

reported in crore

Sector market cap (USD)
$3.74B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹2,864 Cr
+12.11% vs Mar 2025
Net profit · Mar 2026
₹510 Cr
+3.58% vs Mar 2025
Operating margin
23.4%
was 24.5%
Revenue CAGR · 4p
11.6%
profit 28.4% · op 24.8%
Filed order
Revenue2,8642,5552,2962,059
Revenue growthreported12.1%11.3%11.5%—
Operating profit669625506344
Operating profit growthreported7.1%23.6%47.0%—
Operating marginderived23.4%24.5%22.0%16.7%
Net profit510492362241
Net profit growthreported3.6%35.9%50.3%—
Net marginderived17.8%19.3%15.8%11.7%
EPS — basic₹/share, annual30.2429.2443.0528.82

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹3,146 Cr
+15.80% YoY
Total liabilities
₹605 Cr
Net worth
₹2,541 Cr
Liabilities ÷ assets
19.2%
lower means a lighter balance sheet
Filed order
Total assets3,1462,7172,4562,386
Total liabilities605510571686
Net worthderived2,5412,2061,8851,700
Liabilities ÷ assetsderived19.2%18.8%23.2%28.8%
Asset growthderived15.8%10.6%3.0%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets1,5801,3531,3291,412
Current Assets1,5661,3641,127973
Total Assets3,1462,7172,4562,386
Current Liabilities451402465470
Net Current Asset1,116961662503
Non-Current Liabilities154108105216
Equity Capital2,5412,2061,8851,700
Total Equity & Liabilities3,1462,7172,4562,386

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹636 Cr
+11.73% YoY
Investing
-₹422 Cr
Financing
-₹264 Cr
Free cash flow
₹214 Cr
operating + investing
Filed order
Operating activities636569535456
Operating changereported11.7%6.3%17.4%—
Investing activities-422-303-24-287
Investing changereported-39.1%-1149.1%91.5%—
Financing activities-264-334-414-283
Financing changereported21.1%19.3%-46.1%—
Net cash flowderived-50-6897-114
Free cash flowoperating + investing214266511169

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax510492362241
Income before WC changes784732632527
Change in Assets-37-18-1325
Change in Liabilities64194910
Change in WC2713635
Cash flow from Operations636569535456
Cash flow from Investing-422-303-24-287
Cash flow from Financing-264-334-414-283
Total Cash Flow-50-6897-114
Cash (Start of the year)293361264378
Cash (End of the year)243293361264

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
52.93%
-0.26 pts QoQ
FII
18.73%
+1.37 pts QoQ
DII (other)
2.89%
+0.09 pts QoQ
Mutual funds
18.68%
-0.11 pts QoQ
Retail & others
6.76%
-1.10 pts QoQ
Filed order
Promoters52.9%53.2%53.2%53.2%
FII18.7%17.4%17.2%20.3%
DII (other)2.9%2.8%2.8%2.4%
Mutual funds18.7%18.8%18.6%16.8%
Retail & others6.8%7.9%8.2%7.3%
Promoters — QoQ changepts, derived-0.3%-0.0%-0.0%—
FII — QoQ changepts, derived1.4%0.2%-3.1%—
DII (other) — QoQ changepts, derived0.1%0.0%0.4%—
Mutual funds — QoQ changepts, derived-0.1%0.2%1.8%—
Retail & others — QoQ changepts, derived-1.1%-0.4%0.9%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

Type
DividendInterim₹5.0050.0%11 Nov 202611 Nov 202604 Nov 2026
DividendInterim₹5.0050.0%30 Jul 202630 Jul 202624 Jul 2026
DividendFinal₹4.0040.0%25 Jun 202626 Jun 202630 Apr 2026
DividendInterim₹3.5035.0%05 Feb 202605 Feb 202630 Jan 2026
Bonus1:1—19 Dec 202519 Dec 202531 Oct 2025

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue2,7632,4612,2272,017
Other Income101936942
Total Revenue2,8642,5552,2962,059
Total Expenses2,1651,9301,7901,715
Profit Before Tax669625505344
Tax159133143103
Profit After Tax510492362241
EPS - Basic30.2429.2443.0528.82
EPS - Diluted30.2029.2042.9828.74

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.